In thyroid cancer, lncRNA MALAT1 competitively binds to miR-204, upregulates IGF2BP2 and enhances MYC expression in m6A-dependent manner, conferring a stimulatory effect on cancer progression (Ye et al., 2021). The gene discussed is MYC; the disease is cancer.